Skip to content

Discontinued — last reported Q4 '17

Gross margin at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
86.1%+7.2pp
LQD
Liquidia CorporationLQDA
58.1%-18.7pp
United Therapeutics logo
United TherapeuticsUTHR
86.6%-2.4pp
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
89.7%+1.5pp
Organon logo
OrganonOGN
52.8%-4.4pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp

Other financials

Income statement

See full
Revenue$17.7M+15.0%
Operating income-$9.5M+34.3%
Net income-$4.9M+63.7%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$288.1M+160%
Total debt$40.5M-15.9%
Total equity$290.6M+75.1%
Total assets$472.3M+37.5%

Cash flow

See full
Operating cash flow$73.3M+70.3%
CapEx$8.0K-95.8%
Free cash flow$59.6M+5,560%

Valuation

See full
Market cap$890.32M+67.5%
Enterprise value$642.72M+37.0%
P/E7.8×
P/S8.1×0.0×

Profitability

See full
Operating margin1.2%+0.6pp
Net margin104.3%+71.4pp
FCF margin221.9%+206pp

Returns & leverage

See full
Return on equity50.2%+36.2pp
Debt / equity0.1×-0.2×
Current ratio13.1×+8.4×

Where this comes from

Calculated from Theravance Biopharma’s reported figures.

Based on trailing twelve months.

The official record: Theravance Biopharma’s 10-K, filed February 27, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.